Physician profile
Daniel A Oehler
NPI 1801921101
$1,209.04
in general payments reported to CMS, 2019-2025
13 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $324 · 2024: $412 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,209.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $430.75 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $175.34 | 2023-2024 | Dupixent |
| Phathom Pharmaceuticals, INC. | $139.52 | 2024 | Voquezna |
| Optinose US, INC. | $118.36 | 2023-2025 | |
| Glaxosmithkline, LLC. | $116.90 | 2023-2025 | Nucala |
| Ars Pharmaceuticals Operations, INC. | $66.43 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $41.43 | 2023 | |
| Abbvie INC. | $28.19 | 2023-2024 | |
| Vertex Pharmaceuticals Incorporated | $25.36 | 2025 | |
| Stryker Corporation | $23.43 | 2025 | Latera |
| Astrazeneca Pharmaceuticals LP | $16.74 | 2025 | Tezspire |
| Inspire Medical Systems, INC. | $14.13 | 2025 | Inspire |
| Polynovo North America LLC | $12.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Oehler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.